|
|
|
Irritable Bowel Syndrome
|
|
|
Printable Version | Email |
| |
|
Irritable bowel syndrome (IBS) is known by a variety of other terms: spastic colon, spastic colitis, mucous colitis and nervous or functional bowel. Usually, it is a disorder of the large intestine (colon), although other parts of the intestinal tract-even up to the stomach can be affected.
When IBS occurs, the colon does not contract normally. Instead, it seems to contract in a disorganized, at times violent, manner. The contractions may be terribly exaggerated and sustained, lasting for prolonged periods of time. One area of the colon may contract with no regard to another. At other times, there may be little bowel activity at all. These abnormal contractions result in changing bowel patterns with constipation being common.
 The colon, the last five feet of the intestine, serves a number of important functions in the body. First, it dehydrates and stores the stool so that, normally, a well-formed soft stool occurs. Second, it quietly propels the stool from the right side over to the rectum, storing it there until it can be evacuated. This movement occurs by rhythmic contractions of the colon. A third very important function is to provide and produce a large number of health benefits, if fed properly with prebiotic plant fibers. The best way to nourish these bacteria is with a prebiotic fiber supplement such as Prebiotin
What Are the Symptoms?
Most IBS symptoms - abdominal pain, diarrhea, constipation, and bloating - are due to abnormal patterns of bowel contraction. Abdominal discomfort or pain often moves around the abdomen rather than staying in one area. These disorganized, exaggerated and painful contractions lead to certain problems. The pattern of bowel movements is often altered. Diarrhea may occur, especially after meals, as the entire colon contracts and moves liquid stool quickly into the rectum. Or, localized areas of the colon may remain contracted for a prolonged time. When this occurs in the section of colon just above the rectum, the stool may be retained for a prolonged period (constipation) and be squeezed into small pellets. Excessive water is removed from the stool which becomes hard.
Also, colon gas may accumulate behind these localized contractions, causing the bowel to swell. So bloating and abdominal distress may occur.
Some patients see gobs of mucous in the stool and become concerned. Mucous is a normal secretion of the bowel, although most of the time it cannot be seen. IBS patients sometimes produce large amounts of mucous, but this is not abnormal nor a problem.
IBS Is Not a Disease
 Although the symptoms of IBS may be severe, the disorder itself is not a serious one. There is no actual disease present in the colon. In fact, an operation performed on the abdomen would reveal a perfectly normal appearing bowel.
Rather, it is a problem of abnormal function. The condition usually begins in young people, often below 40. It is not uncommon in the teens. The symptoms may wax and wane, being particularly severe at some times and absent at others. Over the years, the symptoms tend to become less intense.
IBS is very common and is present in perhaps half the patients that see a specialist in gastroenterology. It tends to run in families. The disorder does not lead to cancer. Prolonged contractions of the colon, however, may lead to diverticulosis, a disorder in which balloon-like pockets push out from the bowel wall because of excessive, prolonged contractions.
Causes
While our knowledge is still incomplete about the function and malfunction of the large bowel, some facts are well-known. Certain foods, such as coffee, alcohol, spices, some raw fruits and vegetables, and, in some people, even milk can cause the gut to malfunction. In these instances, avoidance of these foods is the simplest treatment.
The colon contains a very large number of bacteria types. This is normal and healthy. Very surprisingly, in 2007 it was found that IBS patients had a significantly different makeup of bacteria within the colon. It is likely that a key part of IBS treatment is changing this bacterial makeup by the use of prebiotics.
Infections, illnesses and even changes in the weather somehow can be associated with a flare-up in symptoms. So can the premenstrual cycle in the female.
By far, the most common factor associated with symptoms of IBS is the interaction between the brain and the gut. The bowel has a rich supply of nerves that are in communication with the brain. Virtually everyone has had, at one time or another, some alteration in bowel function when under intense stress, such as before an important athletic event, school examination, or a family conflict. However, people with IBS seem to have an overly sensitive bowel, and perhaps an overabundance of nerve impulses flowing to the gut, so that the ordinary stresses and strains of living somehow result in colon malfunction.
These exaggerated contractions can be demonstrated experimentally by placing pressure-sensing devices in the colon. Even at rest, with no obvious stress, the pressures tend to be higher than normal. With the routine interactions of daily living, these pressures tend to rise dramatically. When an emotionally charged situation is discussed, they can reach extreme levels not attained in people without IBS. These symptoms are due to real physiologic changes in the gut – a gut that tends to be inherently overly sensitive, and one that overreacts to the stresses and strains of ordinary living.
Diagnosis
 The diagnosis of IBS often can be suspected just by a review of the patient's medical history. In the end, however, it is a diagnosis of exclusion; that is, other conditions of the bowel need to be ruled out before a firm diagnosis of IBS can be made.
A number of diseases of the gut, such as inflammation, cancer, and infection, can mimic some or all of the IBS symptoms. Certain medical tests are helpful in making this diagnosis, including blood, urine and stool exams, x-rays of the intestinal tract and a lighted tube exam of the lower intestine. This exam is called endoscopy, either sigmoidoscopy or colonoscopy.
Additional tests may be required, depending on the specific circumstances in each case. If the proper medical history is obtained and if other diseases are ruled out, a firm diagnosis of IBS can then usually be made.
Treatment
The treatment of IBS is directed to both the psyche and the gut. One key elements is diet. For a complete review of the most current thoughts on diet in IBS patients, go to Irritable Bowel Syndrome Dietary Therapy.
Current medical thinking about diet has changed a great deal in recent years. There is good evidence to suggest that, where tolerated, a high roughage and bran diet is helpful (High Fiber Diet). This diet can result in larger, softer stools which seem to reduce the pressures generated within the colon. In particular, you should select vegetables, fruits and whole grains that are high in insoluble fiber as these fibers do not promote gas. Go to Fiber Content of Foods for information.
Prebiotics are a more recently discovered form of soluble plant fibers. These specially formulated soluble fibers stimulate the growth of good bacteria in the colon producing certain well-defined health benefits. Therefore a prebiotic fiber supplement such as Prebiotin is indicated as part of the diet. Initially, excessive colon gas may occur. The best thing to do is try small amounts and see what the response and symptoms are.
As many people have already discovered, the simple act of eating may, at times, activate the colon. This action is a normal reflex, although in IBS patients it can be exaggerated. In these instances, it is sometimes helpful to eat smaller, more frequent meals to reduce this reflex.
There are certain medications that help the colon by relaxing the muscles in the wall of the colon, thereby reducing the bowel pressure. These drugs are called antispasmodics. Since stress and anxiety may play a role in these symptoms, it can at times be helpful to use a mild sedative, often in combination with an antispasmodic.
Physical exercise, too, is helpful. During exercise, the bowel typically quiets down. If exercise is used regularly and if physical fitness or conditioning develops, the bowel may tend to relax even during non-exercise periods. The invigorating effects of conditioning, of course, extend far beyond the intestine and can be recommended for general health maintenance.
As important as anything else in controlling IBS is learning stress reduction, or at least how to control the body's response to stress. It certainly is well-known that the brain can exert controlling effects over many organs in the body, including the intestine.
Summary
Patients with IBS can be assured that nothing serious is wrong with the bowel. Prevention and treatment may involve a simple change in certain daily habits, reduction of stressful situations, eating better, carefully trying fiber foods and supplements, and exercising regularly.
Perhaps the most important aspect of treatment is reassurance. For most patients, just knowing that there is nothing seriously wrong is the best treatment of all, especially if they can learn to deal with their symptoms on their own.
Send Page To a Friend
|
Medical References
BACKGROUND: Prebiotics are short-chain carbohydrates that alter the
composition, or metabolism, of the gut microbiota in a beneficial
manner. It is therefore expected that prebiotics will improve health in
a way similar to probiotics, whilst at the same time being cheaper, and
carrying less risk and being easier to incorporate into the diet than
probiotics. AIM: To review published evidence for prebiotic effects on
gut function and human health. METHODS: We searched the Science
Citation Index with the terms prebiotic, microbiota, gut bacteria,
large intestine, mucosa, bowel habit, constipation, diarrhoea,
inflammatory bowel disease, Crohn's disease, ulcerative colitis,
pouchitis, calcium and cancer, focussing principally on studies in
humans and reports in the English language. Search of the Cochrane
Library did not identify any clinical study or meta-analysis on this
topic. RESULTS: Three prebiotics, oligofructose,
galacto-oligosaccharides and lactulose, clearly alter the balance of
the large bowel microbiota by increasing bifidobacteria and
Lactobacillus numbers. These carbohydrates are fermented and give rise
to short-chain fatty acid and intestinal gas; however, effects on bowel
habit are relatively small. Randomized-controlled trials of their
effect in a clinical context are few, although animal studies show
anti-inflammatory effects in inflammatory bowel disease, while calcium
absorption is increased. CONCLUSIONS: It is still early days for
prebiotics, but they offer the potential to modify the gut microbial
balance in such a way as to bring direct health benefits cheaply and
safely.
PURPOSE OF REVIEW: This review summarizes the clinical efficacy of
probiotics and prebiotics in gastrointestinal disorders and examines
the mechanisms of action related to their therapeutic effect. RECENT
FINDINGS: The demonstration that immune and epithelial cells can
discriminate between different microbial species has extended the known
mechanism(s) of action of probiotics beyond simple barrier and
antimicrobial effects. It has also confirmed that probiotic bacteria
modulate mucosal and systemic immune activity and epithelial function.
The progressive unraveling of these mechanisms of action has led to new
credence for the use of probiotics and prebiotics in clinical medicine.
Level I evidence now exists for the therapeutic use of probiotics in
infectious diarrhea in children, recurrent Clostridium
difficile-induced infections and postoperative pouchitis. Level II
evidence is emerging for the use of probiotics in other
gastrointestinal infections, prevention of postoperative bacterial
translocation, irritable bowel syndrome, and in both ulcerative colitis
and Crohn disease. Nevertheless, one consistent feature has emerged
over the past year: Not all probiotic bacteria have similar therapeutic
effects. Future clinical trials will need to incorporate this fact into
trial planning and design. SUMMARY: The use of probiotics and
prebiotics as therapeutic agents for gastrointestinal disorders is
rapidly moving into the "mainstream." Mechanisms of action explain the
therapeutic effects and randomized; controlled trials provide the
necessary evidence for their incorporation into the therapeutic
armamentarium.
Patients with irritable bowel syndrome (IBS) often request dietary
recommendations. They must eat, and they want to know what to eat.
Present national guidelines recommend dietary treatment with fiber for
IBS patients with constipation. Diet recommendations are made based on
symptoms. There may be different dietary recommendations for
constipation, diarrhea, and pain or bloating. This article reviews the
relationship of foods to IBS and issues of food intolerances and
hypersensitivities, and recommendations for diet therapy. The role of
dietary fiber, both soluble and insoluble, is reviewed. Although there
are few studies to substantiate exact diets, broad dietary plans are
recommended for the different symptoms of IBS. In addition, the recent
literature on probiotics and prebiotics pertinent to IBS is reviewed.
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is a significant
gastrointestinal disorder with unknown etiology. The symptoms can
greatly weaken patients' quality of life and account for notable
economical costs for society. Contribution of the gastrointestinal
microbiota in IBS has been suggested. Our objective was to characterize
putative differences in gastrointestinal microbiota between patients
with IBS and control subjects. These differences could potentially have
a causal relationship with the syndrome. METHODS: Microbial genomes
from fecal samples of 24 patients with IBS and 23 controls were
collected, pooled in a groupwise manner, and fractionated according to
their guanine cytosine content. Selected fractions were analyzed by
extensive high-throughput 16S ribosomal RNA gene cloning and sequencing
of 3753 clones. Some of the revealed phylogenetic differences were
further confirmed by quantitative polymerase chain reaction assays on
individual sampl es. RESULTS: The coverage of the clone libraries of
IBS subtypes and control subjects differed significantly (P <
.0253). The samples were also distinguishable by the Bayesian analysis
of bacterial population structure. Moreover, significant (P < .05)
differences between the clone libraries were found in several bacterial
genera, which could be verified by quantitative polymerase chain
reaction assays of phylotypes belonging to the genera Coprococcus,
Collinsella, and Coprobacillus. CONCLUSIONS: The study showed that
fecal microbiota is significantly altered in IBS. Further studies on
molecular mechanisms underlying these alterations are needed to
elucidate the exact role of intestinal bacteria in IBS.
|
|
|
|